T-cell receptor complex and co-stimulatory molecules involved in T-cell activation (TCR (T-cell receptor) complex and co-stimulatory receptors such as CD28)

The process termed "T-cell activation stimulation" primarily involves engagement and signal transduction through the T-cell receptor complex, composed mainly of variable α/β chains responsible for antigen recognition presented by MHC molecules on antigen-presenting cells. This interaction triggers intracellular phosphorylation cascades initiated by Src family kinases Lck and Fyn acting on ITAM motifs within associated invariant subunits—CD3ε, γ, δ—and ζ chains. The recruitment and phosphorylation-dependent activation cascade continues with ZAP70 kinase phosphorylating adaptor proteins like LAT that assemble multi-protein complexes propagating signals downstream into multiple pathways including MAPKs ERK/JNK/p38; transcription factors NFAT/NF-kB/AP1 are activated ultimately driving gene expression changes necessary for clonal expansion, differentiation into effector/memory/regulatory phenotypes, cytokine production notably interleukin‑2 secretion essential for survival/proliferation signals. Effective full-scale activation requires additional costimulation primarily mediated by surface receptors such as CD28 binding B7 ligands on APCs which prevent anergy/apoptosis while promoting robust responses. Other members like GITR and TNFR family member 4–1BB provide further modulatory roles particularly relevant in contexts like cancer immunity where their expression correlates with suppressive regulatory populations influencing prognosis. Negative regulators including CTLA4 maintain homeostasis preventing excessive inflammation or autoimmunity ensuring balanced immune responses[1][2][3][4][5][6][7][8]. This comprehensive understanding enables targeted therapeutic interventions aiming either at boosting immunity against infections/cancers or dampening pathological autoimmunity/allergic reactions through manipulation at various points along this critical pathway.

Other names

T-cell receptor signalingTCR signaling pathwayCD3/CD28-mediated activationCo-stimulatory receptors of T cells (e.g., CD28, 4-1BB, GITR)Immune synapse components

Drugs modulate: * Engagement/blockade of the α/β chains on the TCR complex to initiate/inhibit antigen recognition. * Co-stimulation through ligation/blockade of CD28 with B7 ligands enhancing IL‑2 production and preventing anergy. * Activation/phosphorylation cascades involving Lck kinase phosphorylation of ITAMs on CD3 subunits leading to recruitment/activation of ZAP70 kinase. * Downstream adaptor protein phosphorylation triggering MAPK pathways (ERK/JNK/p38), NFAT/NF-kB/AP1 transcription factors that regulate gene expression for proliferation/differentiation/apoptosis.